Start with the fund's observed price, risk, structure, holdings weights, and holdings-weighted company fundamentals; then use the focused tabs to research only this ETF's governed company sleeve.
252 observations · USD · distributions not reinvested.
252 plotted 1Y observations reconcile to the latest dashboard close.
tradingview_etf_holdings · Jul 20, 2026 · current
| Mapped company | Sector | Fund weight |
|---|---|---|
| Eli Lilly and CompanyNYSE:LLY | Health Technology | 15.78% |
| Johnson & JohnsonNYSE:JNJ | Health Technology | 10.42% |
| AbbVie Inc.NYSE:ABBV | Health Technology | 7.79% |
| UnitedHealth Group IncorporatedNYSE:UNH | Health Services | 6.66% |
| Merck & Company, Inc.NYSE:MRK | Health Technology | 5.35% |
| Amgen Inc.NASDAQ:AMGN | Health Technology | 3.42% |
| Thermo Fisher Scientific IncNYSE:TMO | Health Technology | 3.40% |
| Abbott LaboratoriesNYSE:ABT | Health Technology | 3.08% |
| Gilead Sciences, Inc.NASDAQ:GILD | Health Technology | 2.88% |
| Pfizer, Inc.NYSE:PFE | Health Technology | 2.45% |
| Reported holding | Legal asset class | Sector | XLV weight |
|---|---|---|---|
| NYSE:LLYEli Lilly and Company | equity | Health Technology | +15.78% |
| NYSE:JNJJohnson & Johnson | equity | Health Technology | +10.42% |
| NYSE:ABBVAbbVie, Inc. | equity | Health Technology | +7.79% |
| NYSE:UNHUnitedHealth Group Incorporated | equity | Health Services | +6.66% |
| NYSE:MRKMerck & Co., Inc. | equity | Health Technology | +5.35% |
| NASDAQ:AMGNAmgen Inc. | equity | Health Technology | +3.42% |
| NYSE:TMOThermo Fisher Scientific Inc. | equity | Health Technology | +3.40% |
| NYSE:ABTAbbott Laboratories | equity | Health Technology | +3.08% |
| NASDAQ:GILDGilead Sciences, Inc. | equity | Health Technology | +2.88% |
| NYSE:PFEPfizer Inc. | equity | Health Technology | +2.45% |
All 59 mapped positive-weight company rows reconcile to the 99.89% company sleeve. TradingView-reported latest composition; responses above 1,000 rows remain explicitly partial.
ready · normalized reference weights · ratios are not leverage-scaled.
| Metric | Weighted value | Period | Formula | Eligibility / exclusions | Companies | Metric fund weight | Distribution | Status |
|---|---|---|---|---|---|---|---|---|
| P/E TTM | 29.15x | TTM | weighted harmonic mean | positive finite values5 missing value | 54 | 98.3% | Unweighted · median 27.07x | ready |
| P/B FQ | 4.23x | FQ | weighted harmonic mean | positive finite values10 missing value | 49 | 65.5% | Unweighted · median 3.02x | partial |
| P/S current | 1.59x | current | weighted harmonic mean | positive finite valuesNo reported exclusions | 59 | 99.9% | Unweighted · median 3.30x | ready |
| Gross margin | 64.9% | current provider value | weighted arithmetic mean | signed finite values; non-financial operating companies6 missing value | 53 | 88.1% | Unweighted · median 60.7% | ready |
| Net margin | 16.5% | current provider value | weighted arithmetic mean | signed finite values1 missing value | 58 | 98.9% | Unweighted · median 11.7% | ready |
| Return on equity | 44.1% | current provider value | weighted arithmetic mean | signed finite values9 missing value | 50 | 67.7% | Unweighted · median 14.1% | partial |
| Return on assets | 10.2% | current provider value | weighted arithmetic mean | signed finite values3 missing value | 56 | 85.4% | Unweighted · median 5.7% | ready |
| Debt / equity | 1.27x | current provider value | weighted arithmetic mean | non-negative finite values; non-financial companies10 missing value | 49 | 65.5% | Unweighted · median 0.71x | partial |
| Current ratio | 1.52x | current provider value | weighted arithmetic mean |
XLV company holdings Jul 20, 2026 · tradingview_etf_holdings; fundamentals through Jul 21, 2026 · tradingview_company_fundamentals · current only revised. Current/revised company values are joined to the latest holdings; they are not asserted to have been known on the holdings date.
No inferred metadata or missing-to-zero substitution.
Latest stored issuer identity; this does not supply fees, index, NAV, or distribution evidence. NAV, premium/discount, distributions, and benchmark tracking require daily NAV, cash-distribution, and official benchmark total-return feeds that are not connected.
Use the dedicated ETF surfaces for performance/risk and provider flow evidence; use the tabs above for the governed constituent-company cohort.
| non-negative finite values; non-financial companies4 missing value |
| 55 |
| 83.2% |
| Unweighted · median 1.52x |
| ready |
| Quick ratio | 1.24x | current provider value | weighted arithmetic mean | non-negative finite values; non-financial companies9 missing value | 50 | 72.4% | Unweighted · median 1.22x | ready |
|---|
| Dividend yield | 1.6% | current | weighted arithmetic mean | non-negative finite valuesNo reported exclusions | 59 | 99.9% | Unweighted · median 0.6% | ready |
|---|